Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Aug 2026 for OptimizeRx Corp. Read the official filing
Filing timeline
BuySaleMarion Odence-Ford
Insider track record
Disclosed buys
1
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+13.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Marion Odence-Ford: trading record in brief
Marion Odence-Ford, listed as senior executive, appears in our data through filings on OptimizeRx Corp shares, published by SEC (Form 4). The record holds 25 filings, for trades running from 11 February 2022 to 21 August 2026.
The open-market side counts 1 purchase for €16k alongside 1 sale for €55k. Sales outweigh purchases by €40k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants and 16 option exercises.
The latest filing, published on 24 August 2026, reports a share grant in OptimizeRx Corp. The last purchase on record was published on 30 August 2022, which is 1,510 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Marion Odence-Ford
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
57,600 shares0Common StockSEC:0001628280-26-058669:0
1,529 shares@ US$7.710.010% mcap7.5% of flowCommon StockSEC:0001628280-26-058586:0
4,000 sharesCommon StockSEC:0001628280-26-007972:0
4,051 shares@ US$12.7435.2% of flowCommon StockSEC:0001628280-25-058763:0
3,928 shares0Common StockSEC:0001628280-25-058411:0
6,649 shares0Common StockSEC:0001628280-25-044549:0
15,625 shares0Common StockSEC:0001628280-25-041117:0
771 shares0Common StockSEC:0001628280-25-009628:0
1,479 shares@ US$6.6411.6% of flowCommon StockSEC:0001628280-25-006687:0
4,000 sharesCommon StockSEC:0001628280-25-005384:0
41,408 shares0Common StockSEC:0001628280-24-052486:0
3,927 shares0Common StockSEC:0001628280-24-052287:0
1,785 shares0Common StockSEC:0001628280-24-046917:0
6,649 shares0Common StockSEC:0001628280-24-042476:0
4,267 shares0Common StockSEC:0001628280-24-017550:0
771 shares0Common StockSEC:0001628280-24-009405:0
4,000 shares0Common StockSEC:0001628280-24-004575:0
4,000 shares@ US$15.187768.8% of flowCommon StockSEC:0001628280-24-001190:0
1,785 shares0Common StockSEC:0001628280-23-038536:0
6,649 shares0Common StockSEC:0001628280-23-034061:0
771 shares0Common StockSEC:0001628280-23-006262:0
4,000 shares0Common StockSEC:0001628280-23-003460:0
1,785 shares0Common StockSEC:0001628280-22-029460:0
1,000 shares@ US$15.7519.6% of flowCommon StockSEC:0001213900-22-052320:0
Canonical exit: 24 Nov 2022 (T+90)
4,000 sharesCommon StockSEC:0001213900-22-007910:0
25 of 25 declarations
